Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo - Konstantopoulos, N; Molero, J C; McGee, S L; Spolding, B; Connor, T; de Vries, M; Wanyonyi, S; Fahey, R; Morrison, S; Swinton, C; Jones, S; Cooper, A; Garcia-Guerra, L; Foletta, V C; Krippner, G; Andrikopoulos, S; Walder, K R (Diabetes, 2012)